Elizabeth Budde

832 citations
26 papers · 275 indexed · h-index 9

Elizabeth Budde

24 papers receiving 273 citations

Peers

Elizabeth Budde
Comparison fields: 5 of 40
  • Hematology 88
  • Oncology 161
  • Genetics 38
  • Pathology and Forensic Medicine 63
  • Immunology 48
Replace Rawan Faramand with:
Rawan Faramand United States
Maria Laura Milani Italy
Yoshiaki Kuroda Japan
Kaiyang Ding China
Patricia Kropf United States
Raphael Teipel Germany
Juan Esteban García-Robledo United States
Cyrus Khan United States
Seren Durer United States
Rodica Morariu-Zamfir United States
Elizabeth Budde relative to Rawan Faramand United States Rawan Faramand's profile →
Citations per field
00.5×1.6×
Rawan Faramand · 1×
Citations per year

Countries citing papers authored by Elizabeth Budde

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Budde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Budde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Budde more than expected).

Fields of papers citing papers by Elizabeth Budde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Budde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Budde. The network helps show where Elizabeth Budde may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elizabeth Budde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elizabeth Budde Line = papers co-authored together Elizabeth Budde links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 202227
4 202122
5 20215
6 20211
7 20218
8 20214
9 20211
10 202015
11 201929
12 201935
13 201954
14 20185
15 201827
16 20178
17 20153
18 20152
19 20142
20 20144

About Elizabeth Budde

Elizabeth Budde is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine, having authored 26 papers that have together received 275 indexed citations. Recurring topics across this work include CAR-T cell therapy research (19 papers), Lymphoma Diagnosis and Treatment (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Biosimilars and Bioanalytical Methods (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Hematology (88 citations), Oncology (161 citations) and Genetics (38 citations). Elizabeth Budde has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Ibrahim Aldoss, Stephen J. Forman, Samer K. Khaled, Anthony S. Stein, Enkhtsetseg Purev, Brett M. Stevens, Steven T. Rosen, Vinod Pullarkat, Craig T. Jordan and Jonathan A. Gutman. Their work appears in journals such as Blood, Hematological Oncology, Biology of Blood and Marrow Transplantation, Current Oncology Reports and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026